2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Hepatitis C Market?

The hepatitis C market’s expansion is predicted to be driven by a surge in viral infections. These infections are the result of viruses entering the body. By eradicating the virus and restoring the immune response post-viral clearance, patients with hepatitis C can decrease their viral infection. For example, the percentage of individuals affected by Parvovirus B19, a seasonal respiratory viral infection, increased across all age groups from 3% throughout 2022-2024, to 10% in June 2024 according to data from the Centers for Disease Control and Prevention, a US-based public health agency. The most significant increase was seen in children aged 5-9 years, with prevalence rates jumping from 15% during 2022-2024 to 40% by June 2024. Furthermore, the proportion of pooled samples revealing parvovirus B19 DNA levels rose substantially from 1.5% in December 2023 to 19.9% in June 2024. Hence, the upswing in viral infections is fuelling the growth of the hepatitis C market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

#What is the Growth Potential of the Hepatitis C Market, and How Will It Perform by 2034?

The market size for hepatitis C has experienced speedy growth in the recent past. It is predicted to increase from a value of $67.17 billion in 2024 to an estimated $76.32 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. Factors contributing to this surge during the historical phase include blood transfusion procedures, use of injection drugs, a scarcity of treatment alternatives, and the invention of direct-acting antivirals (DaaS).

The market size for hepatitis C is anticipated to experience swift expansion in the upcoming years, increasing to $134.03 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 15.1%. The surge during this projected period can be linked to coordinated global eradication approaches, enhanced testing procedures and screenings, spiraling healthcare expenses, the incorporation of telemedicine, and the emergence of innovative therapy combinations. Principal trends predicted for this period involve accessible and cost-effective treatment options, emphasis on markedly at-risk demographics, refinement of drug formulas, symbiotic collaborations and partnerships, along with the integration of telehealth and digital advancements.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

What Are the Key Market Innovations in theHepatitis C Market Over the Coming Years?

Emerging technologies in hepatitis C diagnostics are becoming a predominant trend in the hepatitic C market. Prominent organizations in the market are employing these new technologies to maintain their market status. Case in point, F. Hoffmann-La Roche Ltd, a pharmaceutical and diagnostics firm from Switzerland, introduced Elecsys HCV Duo immunoassay in countries that are CE Mark compliant in July 2022. The immunoassay Elecsys HCV Duo now gives the ability to independently and concurrently determine the hepatitis C virus (HCV) antigen and antibody status from a single serum or plasma sample from a human. It can diagnose patients showing signs of recovery or chronic infection symptoms that could potentially lead to other illnesses such as liver cancer and other early-stage diseases.

Who Are the Top Companies Driving Innovation and Growth in theHepatitis C Market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Key Market Segments Comprise the Hepatitis C Market and Drive Its Revenue Growth?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Which Regions Are Emerging as Leaders in the Hepatitis C Market?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Hepatitis C Maret 2025, By The Business Research Company:

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Hepatitis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: